TherapeuticsMD (TXMD)
Collects royalties from women’s-health products licensed to pharmaceutical partners.
$2.30
At close+0.13 (+5.99%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions49 holders · as of Mar 31, 2026 | 33.96% | 3.93M shares | |
| Insiders4 holders · as of Dec 29, 2025 | 1.43% | 165.8K shares | |
| Otherremainder | 64.61% | 7.48M shares |
11.57M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
49 holders · 3.93M shares · 11 new positions · 18 increased · 9 reduced · 5 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Rubric Capital Management LP | 1.19M | 10.30% | 0 | May 15, 2026 |
| Clearline Capital LP | 635.2K | 5.49% | 0 | May 15, 2026 |
| Squadron Capital Management LLC | 420.4K | 3.63% | +420.4Knew | May 15, 2026 |
| Vanguard Capital Management LLC | 353.7K | 3.06% | +353.7Knew | May 15, 2026 |
| Tejara Capital Ltd | 345.9K | 2.99% | −5.0K | May 12, 2026 |
| Adar1 Capital Management, LLC | 209.2K | 1.81% | 0 | May 18, 2026 |
| Renaissance Technologies LLC | 146.2K | 1.26% | +49.7K | May 14, 2026 |
| Morgan Stanley | 129.2K | 1.12% | 0 | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Clearline Capital LPincl. Marc Majzner, Clearline Capital LLC | 5.52% | 636.6K | Nov 12, 2024 ↗ | |
| Baselake Partners, LP | 5.20% | 607.2K | 13G | Apr 6, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Dec 23, 2025 | Tommy G. Thompsondirector | Purchase | 8,400 | $1.67 | 23,179 |
CongressHouse and Senate disclosures
Not reported.